Immunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval for a cancer therapeutic based on T cell receptor (TCR) technology. The US regulator ...

The following is a summary of “Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma ...